Posted by Michael Wonder on 23 Oct 2019
'You can't ignore cost': PHARMAC bosses recognise drug-buying constraints, promise transparency
23 October 2019 - PHARMAC's chief executive Sarah Fitt is defending the drug-buying agency in the face of petitioners calling for more drugs to be funded, pointing to financial constraints.
"You can't ignore the cost," Fitt told members of the Health Select Committee on Wednesday. "We're not arguing whether these medicines work or don't work."
Fitt told the committee members PHARMAC has to consider the demand, as well as whether a drug is effective, in order to justify the cost of purchasing it.
